Scientific article
English

Further evidence for amyloid deposition in clinical pancreatic islet grafts

Published inTransplantation, vol. 93, no. 2, p. 219-223
Publication date2012
Abstract

The reasons for the long-term complete or partial loss of islet graft function are unknown, but there are obviously other reasons than just pure allogeneic graft rejection. Earlier studies have shown that deposition of islet amyloid polypeptide amyloid in transplanted islets may indicate a mechanism for loss of β cells.

Keywords
  • Adult
  • Diabetes Mellitus, Type 1/surgery
  • Fatal Outcome
  • Female
  • Humans
  • Immunohistochemistry
  • Islet Amyloid Polypeptide/metabolism
  • Islets of Langerhans/metabolism/pathology
  • Islets of Langerhans Transplantation/adverse effects/mortality/pathology/physiology
  • Liver/metabolism/pathology
  • Male
  • Middle Aged
  • Proprotein Convertase 2/metabolism
  • Tissue Donors
Citation (ISO format)
WESTERMARK, Gunilla T et al. Further evidence for amyloid deposition in clinical pancreatic islet grafts. In: Transplantation, 2012, vol. 93, n° 2, p. 219–223. doi: 10.1097/TP.0b013e31823e46ef
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN0041-1337
584views
0downloads

Technical informations

Creation03/06/2013 13:08:00
First validation03/06/2013 13:08:00
Update13/10/2025 23:30:33
Status update14/03/2023 20:19:37
Last indexation04/02/2026 14:47:14
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack